pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Juul receives FDA clearance for new e-cigarette with optional age-verification feature

Aug 28, 2026·read at STAT ↗RegulatoryNeutral

Juul Labs announced that the U.S. Food and Drug Administration has granted the company permission to market an updated version of its flagship vaping device.

The new model, called Juul2, includes an optional age-verification system that aims to limit access by under-age users. The feature can be activated by retailers or consumers to confirm a buyer’s age before the device is used.

The clearance marks the first time Juul can sell a revised version of its product since its launch over a decade ago, after years of legal challenges and settlements that cost the company about $3 billion and led to workforce reductions.

Juul said it will offer the device with a range of adult-focused flavors beyond tobacco and menthol, while emphasizing that the product is not intended for people who do not already smoke.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Juul gets OK to sell updated vaping device with age-gating technology”

read at STAT ↗
603 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ASTRAZENECA2
drugs
nicotine2nicotine ER2
topics
Approval2AdComCardiology

related stories

  • May 19Opinion: Britain embraces a Massachusetts experiment on tobacco regulation — just as the state might roll it backSTAT
  • Jul 14FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientistSTAT
  • Jul 14The risk of refusing a newborn’s vitamin K shotSTAT
  • Jul 12STAT+: Tau in the spotlight at Alzheimer’s conferenceSTAT
  • Jul 10STAT+: Roche ends Huntington’s gene-silencing programsSTAT